Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Dyadic International Inc (DYAI)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Dyadic's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.470 -0.030    -2.00%
11:07:02 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 869
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.450 - 1.470
Dyadic 1.470 -0.030 -2.00%

Dyadic International Inc Company Profile

 
Get an in-depth profile of Dyadic International Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

7

Equity Type

ORD

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health. The company offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial to demonstrate the safety in humans of a protein produced using the C1 platform. It has also developed the Dapibus thermophilic, a filamentous fungal-based microbial protein production platform to enable the development and large-scale manufacture of cost-effective proteins, metabolites, and other biologic products for use in non-pharmaceutical applications, including food, nutrition, and wellness. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; license agreement with South Africa’s Rubic One Health; Joint Development Agreement with a Global Food Ingredient Company; and sub-license agreement with Abic Biological Laboratories Ltd., Alphazyme, LLC, and Abic Biological Laboratories Ltd. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Contact Information

Address 1044 North U.S. Highway One Suite 201
Jupiter, 33477-5094
United States
Phone 561 743 8333
Fax 561 743 8343

Top Executives

Name Age Since Title
Mark A. Emalfarb 67 2004 Founder, CEO, President & Director
Seth J. Herbst 65 2008 Independent Director
Jack L. Kaye 80 2015 Independent Director
Michael P. Tarnok 67 2014 Independent Director
Arnold L. Demain - - Member of Scientific Advisory Board
Arindam Bose 71 2016 Independent Director
Barry C. Buckland 76 2018 Independent Director
Cees van den Hondel - - Member of Scientific Advisory Board
Arkady P. Sinitsyn - - Member of Scientific Advisory Board
Patrick K. Lucy 56 2021 Independent Chairman
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

DYAI Comments

Write your thoughts about Dyadic International Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Edwin Henriquez
Edwin Henriquez Aug 17, 2021 10:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
do we know what's going on Jesus why this drop
Edwin Henriquez
Edwin Henriquez Aug 16, 2021 2:42PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
we jus broke resistance @5.62 why we any one be selling seriously this could easily go to 8 by this week but we need to hold next resistance is @ 6.55
Edwin Henriquez
Edwin Henriquez Aug 13, 2021 1:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
this will fly by Monday
Faster Hamed
Faster Hamed Aug 11, 2021 11:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Dyadic International (NASDAQ:DYAI) soars 22% premarket after signing a binding term sheet to enter into a License Agreement with Sorrento Therapeutics (NASDAQ:SRNE) to develop and commercialize vaccines, therapeutics, and diagnostics for coronaviruses, including Dyadic’s lead COVID-19 vaccine candidate, DYAI-100, produced using DYAI's proprietary and patented C1-cell protein production platform.“The license agreement, when executed, contemplates an up-front payment of $10 million in cash and stock, up to $4 million in reimbursements for preclinical and clinical development costs incurred by Dyadic for the development and advancement of our proprietary DYAI-100 vaccine, up to $33 million in milestone payments and ongoing royalties following commercialization. All future development costs related to this license will be incurred by Sorrento,” said Mark Emalfarb, Dyadic’s President and CEO.Upon execution, Sorrento will obtain exclusive rights in North and South America, Europe, major
Ashkan Rahimi
Ashkan Rahimi Aug 11, 2021 11:05AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
if they can make it :D
Jeff Bailey
JeffB Jul 28, 2021 5:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
DYAI $3.40 -12.60% @ Close!
Savalis Adkins
Savalis Adkins Mar 02, 2020 8:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I'm thinking by March 9th, this ones gonna be jumpin.
Joshhua Ray
Joshhua Ray Mar 02, 2020 8:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Jumped into June; then 💤😴
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email